Adverse events leading to trial discontinuation occur in 2.6% of semaglutide patients vs 3.3% in placebo
However, the effect of l-valine on blood glucose regulation after an oral glucose tolerance test (OGTT) deserves further investigation, as l-valine could potentially help reduce blood glucose excursions after a carbohydrate-rich meal when given as a preload before the meal due to its GLP-1 stimulatory effect
In nonbariatric patients, some experts even recommend a staged approach with initial GLP1-RA therapy for 1218 months until maximal weight loss is achieved, after which weight loss therapy should be stopped and replaced by lifestyle counseling, with the option of a temporary booster therapy with a weight loss drug in case of significant weight regain [23]
By focusing on a balanced diet rich in fiber, protein, and healthy fats, staying active, managing stress, and supporting gut health, you can enhance this hormones benefits